The head of the Board of Directors of Darnytsia Group said that pharmaceutical companies in Ukraine are not lagging behind the world in terms of technology and quality.
The Covid-19 pandemic acted as a stimulant for the development of pharmaceutical companies around the world. A year after the coronavirus infection spread, these organizations took place in leaders’ ranking in innovation technologies, as Dmytro said during his participation in the Business thinkers forum: Leadership, Strategies, Principles. This news began to spread, according to the Ukrainian News company.
The head of the Darnytsia organization noted that it was the challenges facing all countries due to the emergence of Covid-19 that led to searching for new solutions.
He clarifies that all over the planet, in accordance with international ratings, pharmaceuticals are included in the list of the "most innovative companies" such as Moderna, Pfizer, Novavax, Jonson & Jonson. The vaccine for Covid-19 was created in less than a year, and it is undoubtedly clear that research work in this regard is still underway. However, thanks to the advanced technologies used by pharmaceutical companies, it is possible to accomplish what a few years ago was in people's dreams. So, the search and development of creative solutions are still going on.
It is pharmaceuticals that occupy one of the leading positions here. The company also carries out development and production work because Darnytsia is the largest Ukrainian manufacturer in terms of the volume of manufactured products.
The head of the Board of Directors of Darnytsia Group noted that Ukrainian pharmaceutical companies keep up with the world in terms of technology and quality.
Dmytro Shymkiv shared information that the pharmaceutical sector of Ukraine has been participating in the international market for a long time. Hee understands that the requirements, for example, of European markets, are quite tough and equal to the European Union. Europeans are surprised to see how the Ukrainians are conducting the production process and what the quality of the drug is at the same time. Ukrainians, on the other hand, often value their resources and infrastructure insufficiently.
The innovator also added that Ukrainians practically do not notice the lack of drugs in case of a lockdown. It explains the establishment of a powerful drug production required in the country.